E8 Short oral presentations, Part 1 (Industry & Science)

Monday 29 August 2016
Hilton Buenos Aires : Pacifico B, 3 hours

Organised by the FIP sections and special interest groups



Gabrielle Wiederkehr (Access Regulatory Consulting, Switzerland) and Igor Linhares de Castro (BiocadBrazil, Brazil)



1)    Vancomycin Plasma measurements change prescription in real time against Staphylococcus SPP MIC 2mg/l in critically ill paediatrics          

Silvia Regina Cavani Jorge (Santos University of Sao Paulo, Brazil)


2)    Urinary excretion of ciprofloxacin after administration of extended release tablet in healthy volunteers. Hydrophilic carbomer-ciprofloxacin matrix versus bilayer tablets       

María Eugenia Olivera (Facultad de Ciencias Químicas-Universidad Nacional de Córdoba, Argentina)


3)    Induction of UDP-glucuronosyltransferase 1A1 during the perinatal period can reduce blood thyroxine levels, causing neurodevelopmental toxicity 

Ryoichi Fujiwara (Kitasato University, Japan)


4)    Untargeted metabolomic studies in cardiovascular diseases on the example of early vascular ageing (EVA) syndrome         

Michal Markuszewski (Medical University of Gdansk, Poland)


5)    Comparison of minoxidil penetration when applied on damp or dry scalp      

Tamara Ângelo (Universidade de Brasilia, Brazil)             

15:45 – 16:00 Coffee/tea break


6)    Hypnosis of Propofol is altered by coronary artery bypass grafting in surgical patients as a consequence of reduction on drug plasma protein binding       

Silvia Regina Cavani Jorge (Santos University of Sao Paulo, Brazil)


7)    ƴ-Glutamylcysteine exhibits anti-inflammatory effects via down-regulation of TNF-α and the JNK pathway in acute pancreatitis    

Pablo Marti Andres (Universidad de Valencia, Spain)


8)      Results of a pharmacist-led pharmacogenomics service for community-based frail elderly

Emily Schwartz (Tabula Rasa HealthCare, USA)


9)    Radiopharmaceutical waste disposal in Turkey and the world

A. Yekta Ozer (Hacettepe University, Turkey)


10)  Native-American contribution in Puerto Ricans is associated with a lower warfarin dose requirement            

Karla Claudio (University of Puerto Rico, Puerto Rico)


11)  Driving medicine quality assurance through effective and appropriate utilization of surveillance and screening technologies              

Lukas Roth (U.S. Pharmacopeial Convention, USA)